NCT04682860

Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide: Randomized Double Blind Placebo Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Ankara City Hospital Bilkent · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

One of the most common complaints of admission to the emergency room is gastroenteritis. One of the most common complaints in acute gastroenteritis is abdominal pain. The aim of our study is to investigate whether hyoscine butylbromide used within the indication has an effect on abdominal pain due to acute gastroenteritis. The main purpose of our study is to reduce the pain of the patient at 30th and 60th minutes compared to 0th minute.

Conditions

• Acute Gastroenteritis
• Abdominal Pain

Interventions

Type	Name	Description
DRUG	Hyoscine N Butylbromide	Hyoscine N butylbromide injection for the treatment of abdominal pain in acute gastroenteritis
OTHER	Placebo	2 ml of normal saline injection as placebo

Timeline

• Start date: 2021-09-08
• Primary completion: 2021-12-03
• Completion: 2022-01-03
• First posted: 2020-12-24
• Last updated: 2022-01-04

Locations

1 site across 1 country: Turkey (Türkiye)